Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
PLX51107
i
Other names:
PLX51107, PLX 51107, PLX-51107
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Daiichi Sankyo
Drug class:
BET inhibitor, MYC inhibitor, BRD4 inhibitor
Related drugs:
‹
JQ-1 (27)
ABBV-744 (7)
ZEN-3694 (6)
INCB57643 (4)
BI 894999 (4)
SRA515 (3)
ABBV 075 (3)
GSK525762 (3)
GS-626510 (2)
DAK539 (2)
CPI-203 (1)
RG6146 (1)
ARCC-29 (0)
BET inhibitor (0)
CA2 (0)
CC-95775 (0)
EP31670 (0)
GSK1324726A (0)
INCB054329 (0)
JAB-8263 (0)
NHWD-870 (0)
ODM-207 (0)
OPN-2853 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
ZEN-3219 (0)
ZEN003365 (0)
GS-5829 (0)
RVX 208 (0)
BMS-986158 (0)
BMS-986378 (0)
GT19077 (14)
omacetaxine mepesuccinate (4)
WB100 (3)
RRx-001 (2)
10058-F4 (1)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
APTO-253 (0)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
OTX015 (10)
BI2536 (3)
I-BET151 (2)
SRX3262 (1)
ARV-825 (0)
HH3806 (0)
NEO1132 (0)
NUV-868 (0)
PH-3861 (0)
PH-894 (0)
SRX3177 (0)
JQ-1 (27)
ABBV-744 (7)
ZEN-3694 (6)
INCB57643 (4)
BI 894999 (4)
SRA515 (3)
ABBV 075 (3)
GSK525762 (3)
GS-626510 (2)
DAK539 (2)
CPI-203 (1)
RG6146 (1)
ARCC-29 (0)
BET inhibitor (0)
CA2 (0)
CC-95775 (0)
EP31670 (0)
GSK1324726A (0)
INCB054329 (0)
JAB-8263 (0)
NHWD-870 (0)
ODM-207 (0)
OPN-2853 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
ZEN-3219 (0)
ZEN003365 (0)
GS-5829 (0)
RVX 208 (0)
BMS-986158 (0)
BMS-986378 (0)
GT19077 (14)
omacetaxine mepesuccinate (4)
WB100 (3)
RRx-001 (2)
10058-F4 (1)
ICX-101 (1)
MYCi975 (1)
OMO-103 (1)
APTO-253 (0)
IDP-121 (0)
LMP744 (0)
MRX34 (0)
OTX-2002 (0)
OTX015 (10)
BI2536 (3)
I-BET151 (2)
SRX3262 (1)
ARV-825 (0)
HH3806 (0)
NEO1132 (0)
NUV-868 (0)
PH-3861 (0)
PH-894 (0)
SRX3177 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
quizartinib + PLX51107
Sensitive: D – Preclinical
quizartinib + PLX51107
Sensitive
:
D
quizartinib + PLX51107
Sensitive: D – Preclinical
quizartinib + PLX51107
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
PLX51107
Sensitive: D – Preclinical
PLX51107
Sensitive
:
D
PLX51107
Sensitive: D – Preclinical
PLX51107
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login